Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

por Peyrot, M, Barnett, A H, Meneghini, L F, Schumm-Draeger, P-M
Publicado 2012

Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase...

por Freemantle, N, Meneghini, L, Christensen, T, Wolden, M L, Jendle, J, Ratner, R
Publicado 2013

Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that is unc...

por Meneghini, L., Doshi, A., Gouet, D., Vilsbøll, T., Begtrup, K., Őrsy, P., Ranthe, M. F., Lingvay, I.
Publicado 2019

Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

por Home, P D, Meneghini, L, Wendisch, U, Ratner, R E, Johansen, T, Christensen, T E, Jendle, J, Roberts, A P, Birkeland, K I
Publicado 2012